RGLS logo

Regulus Therapeutics Inc. (RGLS)

Profile

Full Name

Regulus Therapeutics Inc.

Ticker

NASDAQ: RGLS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 9, 2012

Indexes

Not included

Website

http://www.regulusrx.com

Employees

34

Key Details

Price

$8.16

Market cap

$564.95M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.82(+48.10% YoY)

PE ratio

-

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $8.16
    RGLS price is $8.16

    30-Day Relative Volume

    0.00
    RGLS 30-day relative volume is 0.00

    Price Performance

    Price Most recent change

    -
    RGLS price change on Jun 26, 2025 is unknown

    Price YTD change

    +416.46%
    RGLS price is up +416.46% since January 1st

    Price 1-year change

    +385.71%
    RGLS price is up +385.71% year-on-year

    Price 3-year change

    +292.31%
    RGLS price is up +292.31% over the past 3 years

    Price Range

    Price All-time high

    $3072.00
    RGLS price is currently -99.73% below its historical high of $3072.00

    Price 3-year low

    $0.76
    RGLS price is currently +973.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $564.95M
    RGLS market capitalization is $564.95 million

    Market cap 3-year change

    +1755.97%
    RGLS market capitalization is up +1755.97% over the past 3 years

    Market cap All-time high

    $1.07B
    RGLS market capitalization is currently -47.35% below its historical high of $1.07 billion

    Market cap sector rank

    -
    RGLS market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +5.76%
    RGLS shares outstanding is up +5.76% year-on-year

    Shares Outstanding 3-Year Change

    +373.09%
    RGLS shares outstanding is up +373.09% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.02
    RGLS beta is 1.02

    200-day SMA

    $2.83
    RGLS price is currently +188.55% above its 200-day simple moving average

    50-day SMA

    $6.90
    RGLS price is currently +18.28% above its 50-day simple moving average

    RSI

    66.63
    RGLS 14-day relative strength index is 66.63

    Volume

    0.00
    RGLS 30-day relative volume is 0.00

    ATR

    $0.05
    RGLS average true range is $0.05

    10-day Historical Volatility

    28.94%
    RGLS 10-day historical volatility is 28.94%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    RGLS annual revenue value is unknown

    Revenue Analysts estimate

    -
    RGLS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    RGLS annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    RGLS annual revenue is unknown

    EPS

    EPS

    -$0.82
    RGLS annual earnings per share is -$0.82

    EPS Analysts estimate

    -$1.14
    RGLS annual earnings per share is currently -28.07% lower than the consensus analysts' forecast

    EPS 1-year change

    +48.1%
    RGLS annual earnings per share is up +48.1% year-on-year

    EPS Sector rank

    -
    RGLS annual earnings per share is unknown

    Profit

    Gross profit

    -
    RGLS annual gross profit value is unknown

    Gross margin

    -
    RGLS annual gross profit margin value is unknown

    Operating profit

    -$50.04M
    RGLS annual operating income is -$50.04 million

    Operating margin

    -
    RGLS annual operating profit margin value is unknown

    Net income

    -$46.36M
    RGLS annual net profit is -$46.36 million

    Net margin

    -
    RGLS annual net profit margin value is unknown

    Expenses

    Total expenses

    $50.04M
    RGLS annual total expenses is $50.04 million

    Operating expenses

    $50.04M
    RGLS annual total operating expenses is $50.04 million

    Cost of goods sold

    -
    RGLS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $14.67M
    RGLS annual SGA is $14.67 million

    Depreciation and amortization

    $347.00K
    RGLS annual depreciation & amortization is $347.00 thousand

    Interest expense

    $158.00K
    RGLS annual interest expense is $158.00 thousand

    Income tax

    $1000.00
    RGLS annual income tax is $1000.00

    EBIT & EBITDA

    EBIT

    -$46.20M
    RGLS annual earnings before interest & taxes is -$46.20 million

    EBITDA

    -$45.85M
    RGLS annual EBITDA is -$45.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $84.18M
    RGLS annual total assets is $84.18 million

    Non current assets

    $1.84M
    RGLS annual long term assets is $1.84 million

    Current assets

    $82.34M
    RGLS annual total current assets is $82.34 million

    Cash and cash equivalents

    $38.53M
    RGLS annual cash & cash equivalents is $38.53 million

    Accounts receivable

    -
    RGLS annual accounts receivable value is unknown

    Inventory

    -
    RGLS annual inventory value is unknown

    Liabilities

    Total liabilities

    $7.77M
    RGLS annual total liabilities is $7.77 million

    Long term liabilities

    $274.00K
    RGLS annual total long term liabilities is $274.00 thousand

    Current liabilities

    $7.50M
    RGLS annual total current liabilities is $7.50 million

    Accounts payable

    $947.00K
    RGLS annual accounts payable is $947.00 thousand

    Debt

    Total debt

    $274.00K
    RGLS annual total debt is $274.00 thousand

    Total debt 1-year change

    -88.53%
    RGLS annual total debt is down -88.53% year-on-year

    Long term debt

    $274.00K
    RGLS annual long term debt is $274.00 thousand

    Short term debt

    -
    RGLS annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $76.41M
    RGLS annual stockholders equity is $76.41 million

    Book value

    $76.40M
    RGLS annual book value is $76.40 million

    Retained earnings

    -$559.57M
    RGLS annual retained earnings is -$559.57 million

    Working capital

    $74.85M
    RGLS annual working capital is $74.85 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$41.67M
    RGLS annual cash flow from operations is -$41.67 million

    Cash from operations 1-year change

    -55.68%
    RGLS annual cash flow from operations is down -55.68% year-on-year

    Cash from investing

    -$35.98M
    RGLS annual cash flow from investing activities is -$35.98 million

    Cash from investing 1-year change

    -348.31%
    RGLS annual cash flow from investing activities is down -348.31% year-on-year

    Cash from financing

    $92.42M
    RGLS annual cash flow from financing activities is $92.42 million

    Cash from financing 1-year change

    +682.13%
    RGLS annual cash flow from financing activities is up +682.13% year-on-year

    CAPEX

    CAPEX

    -
    RGLS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    RGLS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$42.01M
    RGLS annual free cash flow is -$42.01 million

    Free cash flow 1-year change

    -53.44%
    RGLS annual free cash flow is down -53.44% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    RGLS annual gross profit margin value is unknown

    Operating margin

    -
    RGLS annual operating profit margin value is unknown

    Net margin

    -
    RGLS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -55.07%
    RGLS annual return on assets is -55.07%

    ROE

    -60.67%
    RGLS annual return on equity is -60.67%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    RGLS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    RGLS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    8.18
    RGLS price to book ratio is 8.18

    PB ratio Sector rank

    -
    RGLS price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    RGLS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    RGLS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $516.89M
    RGLS enterprise value is $516.89 million

    Enterprise value Sector rank

    -
    RGLS enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -10.98
    RGLS EV/EBITDA is -10.98

    EV/EBITDA Sector rank

    -
    RGLS EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    10.98
    RGLS annual current ratio is 10.98

    Quick ratio

    -
    RGLS annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    RGLS annual debt to equity ratio is 0.00

    Interest coverage ratio

    -292.40
    RGLS annual interest coverage ratio is -292.40

    Risk & Stability

    Piotroski F-Score

    -
    RGLS piotroski f-score value is unknown

    Altman Z-Score

    -
    RGLS altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    May 1, 25 Wells Fargo
    Equal-Weight
    Apr 30, 25 Leerink Partners
    Market Perform
    Apr 30, 25 Jones Trading
    Hold
    Apr 30, 25 Canaccord Genuity
    Hold
    Mar 27, 25 Wells Fargo
    Overweight
    Mar 17, 25 Canaccord Genuity
    Buy
    Feb 26, 25 HC Wainwright & Co.
    Buy
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Oct 30, 24 HC Wainwright & Co.
    Buy
    Aug 14, 24 Oppenheimer
    Outperform

    Institutional Ownership

    Screeners with RGLS included

    Stocks above SMA 50
    • What is the ticker symbol for Regulus Therapeutics Inc.?
    • Does Regulus Therapeutics Inc. pay dividends?
    • What sector is Regulus Therapeutics Inc. in?
    • What industry is Regulus Therapeutics Inc. in?
    • What country is Regulus Therapeutics Inc. based in?
    • When did Regulus Therapeutics Inc. go public?
    • Is Regulus Therapeutics Inc. in the S&P 500?
    • Is Regulus Therapeutics Inc. in the NASDAQ 100?
    • Is Regulus Therapeutics Inc. in the Dow Jones?
    • When was Regulus Therapeutics Inc.'s last earnings report?
    • When does Regulus Therapeutics Inc. report earnings?

    What is the ticker symbol for Regulus Therapeutics Inc.?

    The ticker symbol for Regulus Therapeutics Inc. is NASDAQ:RGLS

    Does Regulus Therapeutics Inc. pay dividends?

    No, Regulus Therapeutics Inc. does not pay dividends

    What sector is Regulus Therapeutics Inc. in?

    Regulus Therapeutics Inc. is in the Healthcare sector

    What industry is Regulus Therapeutics Inc. in?

    Regulus Therapeutics Inc. is in the Biotechnology industry

    What country is Regulus Therapeutics Inc. based in?

    Regulus Therapeutics Inc. is headquartered in United States

    When did Regulus Therapeutics Inc. go public?

    Regulus Therapeutics Inc.'s initial public offering (IPO) was on October 9, 2012

    Is Regulus Therapeutics Inc. in the S&P 500?

    No, Regulus Therapeutics Inc. is not included in the S&P 500 index

    Is Regulus Therapeutics Inc. in the NASDAQ 100?

    No, Regulus Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Regulus Therapeutics Inc. in the Dow Jones?

    No, Regulus Therapeutics Inc. is not included in the Dow Jones index

    When was Regulus Therapeutics Inc.'s last earnings report?

    Regulus Therapeutics Inc.'s most recent earnings report was on May 8, 2025

    When does Regulus Therapeutics Inc. report earnings?

    The next expected earnings date for Regulus Therapeutics Inc. is August 8, 2025
    On this page